Copyright
©The Author(s) 2023.
World J Med Genet. Dec 20, 2023; 11(4): 39-50
Published online Dec 20, 2023. doi: 10.5496/wjmg.v11.i4.39
Published online Dec 20, 2023. doi: 10.5496/wjmg.v11.i4.39
Patient respondents (n = 25) | Clinician respondents (n = 17) | ||
Sex | Sex | ||
Male | 9 (36.0) | Male | 11 (64.7) |
Female | 16 (64.0) | Female | 6 (35.3) |
Patient age (yr) | Clinician attained medical degree | ||
18-29 | 4 (16.0) | Before 1980 | 2 (11.8) |
30-39 | 2 (8.0) | 1981-1990 | 2 (11.8) |
40-49 | 7 (28.0) | 1991-2000 | 3 (17.6) |
50-59 | 6 (24.0) | After 2000 | 10 (58.8) |
60-69 | 5 (20.0) | ||
> 70 | 1 (4.0) | ||
Patient education level | Clinician specialty | ||
Did not finish high school | 1 (4.0) | Psychiatry | 5 (29.4) |
High school | 6 (24.0) | Clinical pharmacology | 3 (17.6) |
Certificate or diploma | 5 (20.0) | Immunology | 2 (11.8) |
Bachelor’s degree | 11 (44.0) | Neurology | 2 (11.8) |
Master’s degree or doctorate | 2 (8.0) | General practitioner | 1 (5.9) |
Other1 | 7 (41.2) |
- Citation: Moxham R, Tjokrowidjaja A, Devery S, Smyth R, McLean A, Roberts DM, Wu KHC. Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting. World J Med Genet 2023; 11(4): 39-50
- URL: https://www.wjgnet.com/2220-3184/full/v11/i4/39.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v11.i4.39